BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 23058634)

  • 1. Inhibition of ATM blocks the etoposide-induced DNA damage response and apoptosis of resting human T cells.
    Korwek Z; Sewastianik T; Bielak-Zmijewska A; Mosieniak G; Alster O; Moreno-Villanueva M; Burkle A; Sikora E
    DNA Repair (Amst); 2012 Nov; 11(11):864-73. PubMed ID: 23058634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional switching of ATM: sensor of DNA damage in proliferating cells and mediator of Akt survival signal in post-mitotic human neuron-like cells.
    Li Y; Xiong H; Yang DQ
    Chin J Cancer; 2012 Aug; 31(8):364-72. PubMed ID: 22739265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular signal-related kinase positively regulates ataxia telangiectasia mutated, homologous recombination repair, and the DNA damage response.
    Golding SE; Rosenberg E; Neill S; Dent P; Povirk LF; Valerie K
    Cancer Res; 2007 Feb; 67(3):1046-53. PubMed ID: 17283137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of ATM activation, histone H2AX phosphorylation and apoptosis by etoposide: relation to cell cycle phase.
    Tanaka T; Halicka HD; Traganos F; Seiter K; Darzynkiewicz Z
    Cell Cycle; 2007 Feb; 6(3):371-6. PubMed ID: 17297310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ATM inhibitor KU-55933 suppresses cell proliferation and induces apoptosis by blocking Akt in cancer cells with overactivated Akt.
    Li Y; Yang DQ
    Mol Cancer Ther; 2010 Jan; 9(1):113-25. PubMed ID: 20053781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of autophagy in chemoresistance: regulation of the ATM-mediated DNA-damage signaling pathway through activation of DNA-PKcs and PARP-1.
    Yoon JH; Ahn SG; Lee BH; Jung SH; Oh SH
    Biochem Pharmacol; 2012 Mar; 83(6):747-57. PubMed ID: 22226932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of ATM and 53BP1 as predictive markers in cervical cancer.
    Roossink F; Wieringa HW; Noordhuis MG; ten Hoor KA; Kok M; Slagter-Menkema L; Hollema H; de Bock GH; Pras E; de Vries EG; de Jong S; van der Zee AG; Schuuring E; Wisman GB; van Vugt MA
    Int J Cancer; 2012 Nov; 131(9):2056-66. PubMed ID: 22323184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ATM inhibitor KU-55933 increases the TMZ responsiveness of only inherently TMZ sensitive GBM cells.
    Nadkarni A; Shrivastav M; Mladek AC; Schwingler PM; Grogan PT; Chen J; Sarkaria JN
    J Neurooncol; 2012 Dec; 110(3):349-57. PubMed ID: 23054561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth of persistent foci of DNA damage checkpoint factors is essential for amplification of G1 checkpoint signaling.
    Yamauchi M; Oka Y; Yamamoto M; Niimura K; Uchida M; Kodama S; Watanabe M; Sekine I; Yamashita S; Suzuki K
    DNA Repair (Amst); 2008 Mar; 7(3):405-17. PubMed ID: 18248856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic inhibition of ATM kinase provides a strategy for glioblastoma multiforme radiosensitization and growth control.
    Golding SE; Rosenberg E; Adams BR; Wignarajah S; Beckta JM; O'Connor MJ; Valerie K
    Cell Cycle; 2012 Mar; 11(6):1167-73. PubMed ID: 22370485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clioquinol induces DNA double-strand breaks, activation of ATM, and subsequent activation of p53 signaling.
    Katsuyama M; Iwata K; Ibi M; Matsuno K; Matsumoto M; Yabe-Nishimura C
    Toxicology; 2012 Sep; 299(1):55-9. PubMed ID: 22627294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of ataxia telangiectasia mutated kinase activity enhances TRAIL-mediated apoptosis in human melanoma cells.
    Ivanov VN; Zhou H; Partridge MA; Hei TK
    Cancer Res; 2009 Apr; 69(8):3510-9. PubMed ID: 19351839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ATM-dependent and -independent dynamics of the nuclear phosphoproteome after DNA damage.
    Bensimon A; Schmidt A; Ziv Y; Elkon R; Wang SY; Chen DJ; Aebersold R; Shiloh Y
    Sci Signal; 2010 Dec; 3(151):rs3. PubMed ID: 21139141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytometry of ATM activation and histone H2AX phosphorylation to estimate extent of DNA damage induced by exogenous agents.
    Tanaka T; Huang X; Halicka HD; Zhao H; Traganos F; Albino AP; Dai W; Darzynkiewicz Z
    Cytometry A; 2007 Sep; 71(9):648-61. PubMed ID: 17622968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chk1 is dispensable for G2 arrest in response to sustained DNA damage when the ATM/p53/p21 pathway is functional.
    Lossaint G; Besnard E; Fisher D; Piette J; Dulić V
    Oncogene; 2011 Oct; 30(41):4261-74. PubMed ID: 21532626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistence of unrepaired DNA double strand breaks caused by inhibition of ATM does not lead to radio-sensitisation in the absence of NF-κB activation.
    Veuger SJ; Durkacz BW
    DNA Repair (Amst); 2011 Feb; 10(2):235-44. PubMed ID: 21144805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA damage caused by metal nanoparticles: involvement of oxidative stress and activation of ATM.
    Wan R; Mo Y; Feng L; Chien S; Tollerud DJ; Zhang Q
    Chem Res Toxicol; 2012 Jul; 25(7):1402-11. PubMed ID: 22559321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of poly(ADP-ribose) polymerase (PARP) and ataxia telangiectasia mutated (ATM) on the chemosensitivity of mantle cell lymphoma to agents that induce DNA strand breaks.
    Golla RM; Li M; Shen Y; Ji M; Yan Y; Fu K; Greiner TC; McKeithan TW; Chan WC
    Hematol Oncol; 2012 Dec; 30(4):175-9. PubMed ID: 22170260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological inhibition of ATM by KU55933 stimulates ATM transcription.
    Khalil HS; Tummala H; Hupp TR; Zhelev N
    Exp Biol Med (Maywood); 2012 Jun; 237(6):622-34. PubMed ID: 22728709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM.
    Hickson I; Zhao Y; Richardson CJ; Green SJ; Martin NM; Orr AI; Reaper PM; Jackson SP; Curtin NJ; Smith GC
    Cancer Res; 2004 Dec; 64(24):9152-9. PubMed ID: 15604286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.